Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy.

van Veen JJ, Hampton KK, Maclean R, Fairlie F, Makris M.

Blood Transfus. 2007 Nov;5(4):204-9. doi: 10.2450/2007.0023-07.

3.

Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study.

Dargaud Y, Desmurs-Clavel H, Marin S, Bordet JC, Poplavsky JL, Negrier C.

J Thromb Haemost. 2008 Jun;6(6):962-8. doi: 10.1111/j.1538-7836.2008.02964.x. Epub 2008 Mar 27.

4.

In vivo increase in thrombin generation by four-factor prothrombin complex concentrate in apixaban-treated healthy volunteers.

Cheung YW, Barco S, Hutten BA, Meijers JC, Middeldorp S, Coppens M.

J Thromb Haemost. 2015 Oct;13(10):1799-805. doi: 10.1111/jth.13115. Epub 2015 Sep 21.

PMID:
26270625
5.

Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery.

Escobar MA, Auerswald G, Austin S, Huang JN, Norton M, Millar CM.

Haemophilia. 2016 Sep;22(5):713-20. doi: 10.1111/hae.12954. Epub 2016 May 24.

PMID:
27217097
6.

Unusual bleeding manifestations in a case of primary amyloidosis with factor X deficiency but elevations of in vivo markers of thrombin formation and activity.

Marcatti M, Mauri S, Tresoldi M, Sabbadini MG, Vigano'D'Angelo S, Safa O, Rugarli C, D'Angelo A.

Thromb Res. 1995 Nov 15;80(4):333-7.

PMID:
8585046
7.

Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.

Franklin SW, Szlam F, Fernandez JD, Leong T, Tanaka KA, Guzzetta NA.

Anesth Analg. 2016 Apr;122(4):935-42. doi: 10.1213/ANE.0000000000001098.

PMID:
26599794
8.

Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model.

Herzog E, Kaspereit FJ, Krege W, Doerr B, van Ryn J, Dickneite G, Pragst I.

Thromb Res. 2014 Sep;134(3):729-36. doi: 10.1016/j.thromres.2014.07.003. Epub 2014 Jul 11.

9.

In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate.

Barco S, Whitney Cheung Y, Coppens M, Hutten BA, Meijers JC, Middeldorp S.

Br J Haematol. 2016 Jan;172(2):255-61. doi: 10.1111/bjh.13821. Epub 2015 Oct 21.

PMID:
26488126
10.

Severe factor X deficiency in three unrelated Palestinian patients is caused by homozygosity for the mutation c302delG-correlation with thrombin generation and thromboelastometry.

Livnat T, Shenkman B, Kenet G, Tamarin I, Gillis S, Varon D, Iijima K, Zivelin A, Salomon O.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):673-9. doi: 10.1097/MBC.0b013e32834ad785.

PMID:
22008904
11.

Six novel missense mutations causing factor X deficiency and application of thrombin generation test.

Liang Q, Chen Q, Ding Q, Wu F, Wang X, Xi X, Wang H.

Thromb Res. 2013 Jun;131(6):554-9. doi: 10.1016/j.thromres.2013.04.014. Epub 2013 May 7.

PMID:
23664564
12.

Diagnosis and treatment of inherited factor X deficiency.

Brown DL, Kouides PA.

Haemophilia. 2008 Nov;14(6):1176-82. doi: 10.1111/j.1365-2516.2008.01856.x.

PMID:
19141158
13.

Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency.

Austin SK, Brindley C, Kavakli K, Norton M, Shapiro A; FX Investigators Group..

Haemophilia. 2016 May;22(3):426-32. doi: 10.1111/hae.12894. Epub 2016 Feb 15.

PMID:
26879266
14.

A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal.

Kerebel D, Joly LM, Honnart D, Schmidt J, Galanaud D, Negrier C, Kursten F, Coriat P; Lex206 Investigator Group..

Crit Care. 2013 Jan 10;17(1):R4. doi: 10.1186/cc11923.

15.

In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.

Pike GN, Cumming AM, Hay CR, Sempasa B, Sutherland M, Thachil J, Burthem J, Bolton-Maggs PH.

Haemophilia. 2016 May;22(3):403-10. doi: 10.1111/hae.12846. Epub 2015 Nov 11.

PMID:
26558335
16.

General haemostatic agents--fact or fiction?

Hedner U.

Pathophysiol Haemost Thromb. 2002;32 Suppl 1:33-6.

PMID:
12214145
17.

Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.

Kaspereit F, Hoffmann S, Pragst I, Dickneite G.

Br J Anaesth. 2010 Nov;105(5):576-82. doi: 10.1093/bja/aeq216. Epub 2010 Aug 17.

18.

In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban.

Dinkelaar J, Molenaar PJ, Ninivaggi M, de Laat B, Brinkman HJ, Leyte A.

J Thromb Haemost. 2013 Jun;11(6):1111-8. doi: 10.1111/jth.12236.

19.

Correlation of coagulation markers and 4F-PCC-mediated reversal of rivaroxaban in a rabbit model of acute bleeding.

Herzog E, Kaspereit F, Krege W, Mueller-Cohrs J, Doerr B, Niebl P, Dickneite G.

Thromb Res. 2015 Mar;135(3):554-60. doi: 10.1016/j.thromres.2015.01.007. Epub 2015 Jan 9.

20.

Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.

Matsumoto T, Nogami K, Shima M.

Thromb Haemost. 2013 Oct;110(4):761-8. doi: 10.1160/TH13-04-0345. Epub 2013 Aug 29.

PMID:
24072166

Supplemental Content

Support Center